Skip to main content
Fig. 3 | BMC Psychiatry

Fig. 3

From: Hospital utilization rates following antipsychotic dose reduction in mood disorders: implications for treatment of tardive dyskinesia

Fig. 3

Patient claims analyzed for MDD-related inpatient admissions after ≥10% dose reductions of antipsychotic medication. Outcomes for case and control cohorts were assessed using Kaplan–Meier analysis and compared using a log-rank test. The number of patients at risk is represented for each time point. Case and control cohorts for ≥10%, N = 17,766 each. CI: confidence interval; MDD: major depressive disorder

Back to article page